Meaningful Use

You are here: Home / Meaningful Use

Meaningful Use

simplifyMD's Certification Status:

simplifyMD is committed to COMPLETE EHR certification. To enable our users to start attestation before all recently defined modules are complete, we have chosen the Modular Certification, which is done in 4 parts. You may look at the table below to see which modules are certified, as well as the time frame for the remaining sections. Keep in mind the government attestation requires only that your vendor is certified at the time of your attestation, not during the time period of “meaningful use.”

If you have any questions, don’t hesitate to contact us on this important topic: info@simplifyMD.com

simplifyMD, LLC - simplifyMD SP12

Certifying ATCB: CCHIT | Certification #: CC-1112-311000-3
Classification: Modular EHR | Practice Setting: Ambulatory

General Criteria (170.302)
(a) Drug-drug, drug-allergy interaction checks
(b) Drug formulary checks
(c) Maintain up-to-date problem list
(d) Maintain active medication list
(e) Maintain active medication allergy list
(f) Record and chart vital signs
(g) Smoking status
(h) Incorporate laboratory test results
(i) Generate patient lists
(j) Medication reconciliation
(k) Submission to immunization registries
(l) Public health surveillance
(m) Patient specific education resources
(n) Automated measure calculation
(o) Access control
(p) Emergency access
(q) Automatic log-off
(r) Audit log
(s) Integrity
(t) Authentication
(u) General encryption
(v) Encryption when exchanging electronic health information
(w) Accounting of disclosures (optional)
 
Ambulatory Criteria (170.304)
(a) Computerized provider order entry
(b) Electronic prescribing
(c) Record demographics
(d) Patient reminders
(e) Clinical decision support
(f) Electronic copy of health information
(g) Timely access
(h) Clinical summaries
(i) Exchange clinical information and patient summary record
(j) Calculate and submit clinical quality measures

* Certification dates

Module 1
Certification Date:
12/06/2010		 General Crieteria:
c, d, g, o, p, r, s, t, u, v
Ambulatory Crieteria: c
Module 2
Certification Date:
01/19/2011		 General Crieteria:
a, b, e, m
Amb. Crieteria: a, b
Module 3
Certification Date:
08/04/2011		 General Crieteria:
f, j, k, l
Amb. Crieteria: f, g, h, i
Module 4
Certification Date:
08/04/2011		 Gen. Crieteria: h, i, n
Amb. Crieteria: d, e, j
Ambulatory Clinical Quality Measures
NQF 0001 Asthma Assesment
NQF 0002 Pharyngitis- Children
NQF 0004 Alcohol and Drug Dependence
NQF 0012 Prenatal Care: HIV Screening
NQF 0013 Hypertension: Blood Pressure Measurement
NQF 0014 Prenatal Care: Anti-D immune Globulin
NQF 0018 Controlling High Blood Pressure
NQF 0024 Youth Weight Assesment
NQF 0027 Tobacco Use Cessation
NQF 0028 Prevenitive Care: Tobacco Use Assesment and Cessation
NQF 0031 Breat Cancer Screening
NQF 0032 Cervical Cancer Screening
NQF 0033 Chlamydia Screening for Women
NQF 0034 Colorectal Cancer Screening
NQF 0036 Appropriate Medications for Asthma
NQF 0038 Childhood Immunization Status
NQF 0041 Influenza Immunization
NQF 0043 Pnemonia Vaccination
NQF 0047 Asthma Pharmacologic Therapy
NQF 0052 Use of Imaging Study: Low Back Pain
NQF 0055 Diabetes: Eye Exam
NQF 0056 Diabetes: Foot Exam
NQF 0059 Diabetes Control: Hemoglobin A1c >9.0%
NQF 0061 Diabetic Patients who elevated mmhg V140/90
NQF 0062 Nephropathy Screening- Urine
NQF 0064 Diabetes Control: LDL < 100mg/dl
NQF 0067 Antiplatelet Therapy
NQF 0068 Ischemic Vascular Disease: Asparin or other Antithrombotic
NQF 0070 Coronoary Artery Disease: Beta Blocker Therapy Post Myocadial Infarction
NQF 0073 Blood Pressure Management: Ischemic Valve Disease
NQF 0074 Corinary Artery Disease: Lipid Lowering Therapy
NQF 0075 IVD: Complete Lipid Panel and LDL Control
NQF 0081 Heart Failure: ACE/ ARB Therapy For LVSD (LVEF <40%)
NQF 0083 Heart Failure: Beta Blocker for LVSD
NQF 0084 Heart Failure: Warfarin Therapy
NQF 0086 Primary Open Angle Glaucoma
NQF 0088 Diabetic Retinopathy: Macular Edema
NQF 0089 Diabetes Management: Retinopathy Screening
NQF 0105 Depression Management
NQF 0385 Colon Cancer: Chemotherapy
NQF 0387 Breast Cancer: Hormonal Therapy
NQF 0389 Prostate Cancer: Avoid overuse of Bone Scan
NQF 0421 Adult Weight Screening
NQF 0575 Diabetes Control: Hemoglobin A1c <8.0%

simplifyMD has decided to combine testing of Modules 3 and 4 with CCHIT.

  

Receive a free summary of MU* guidelines

* Meaningful Use

Your Solution

simplifyMD
Schedule a Demo ROI Calculator View Case Studies View Press Releases Follow simplifyMD
simpligyMD Guarantee

The simplifyMD Guarantee

We are so confident that simplifyMD will pay for itself in your practice that we've fashioned our terms based on that assumption. Pay one low monthly all-inclusive price for simplifyMD; if you don't save more than it costs or if you are displeased, simply discontinue using it. You can walk away any time without any additional charges. By any measure, simplifyMD succeeds only when you do.